Liver Cancer Patient Survival in Taizhou, China, 2004-2023

12,032 liver cancer patient records from Taizhou, eastern China, diagnosed between 2004 and 2023. The data includes age-standardized 5-, 10-, 15-, and 20-year relative survival rates, stratified by gender, age, and urban versus rural residence. Authored by Pengtao Chen and published on figshare in 2026, this dataset provides serial long-term survival estimates for evaluating screening programs.

Use Cases

• Analyzing temporal improvements in liver cancer survival based on period analysis from 2004 to 2023.
• Comparing survival disparities based on gender, age, and urban-rural residence mentioned in the results.
• Benchmarking early detection and screening program efficacy using the provided 5-year relative survival rates.

Strengths

• Includes 12,032 patient records from a defined population-based cohort.
• Provides specific survival rates, such as a 37.32% 5-year relative survival for 2019-2023.
• Covers a 20-year time range (2004-2023) for longitudinal analysis.
• Stratified by key demographic variables including gender, age group, and residence.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the underlying analytical dataset is unknown, which may limit suitability assessment.
• The 18.6 KB file size suggests the primary data may be summary statistics rather than patient-level records.

Provenance

Source

figshare

Collection Method

Retrospective cohort analysis using period analysis and actuarial methods with adjustments from regional life tables.

Time Range

2004-2023

Freshness

Last updated 2026-04-14 04:20:52; freshness should be verified.

Geography

Taizhou, eastern China